Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis.

Research output: Contribution to journalJournal articleResearch

  1. Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Closure of the fascial defect during laparoscopic umbilical hernia repair: a randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prospective observational cohort study on grading the severity of postoperative complications in global surgery research

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genome-wide cell-free DNA fragmentation in patients with cancer

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations
Twenty-five patients admitted to intensive or high-dependency surgical care units were randomized to receive ranitidine intravenously 50 mg every 6 hours for 8 days or no ranitidine. All had septicemia or intra-abdominal sepsis, with body temperature greater than or equal to 38.5 degrees C for more than 48 hours despite comprehensive medical and/or surgical treatment. Cell-mediated immunity was assessed by skin testing with seven common delayed type hypersensitivity antigens applied on days 1, 4 and 7 and all tests were read at 48 hours, i.e. on days 3, 6 and 9. The ranitidine/non-ranitidine regimen was initiated on day 1 and continued until day 9. Severity of illness was evaluated before and 3, 6 and 8 days after initiating the study, using the APACHE II scoring system. The scores before and during the study were similar in the ranitidine and non-ranitidine groups. Delayed type hypersensitivity improved in patients treated with ranitidine (p less than 0.001), but was unchanged in the untreated group (p greater than 0.7). These observations may suggest potential beneficial effects of ranitidine therapy in patients with trauma-induced immunosuppression.
Translated title of the contributionRanitidine for improvement of delayed hypersensitivity response in patients with sepsis.
Original languageEnglish
JournalEuropean Journal of Surgery
Volume155
Issue number9
Pages (from-to)445-449
Number of pages5
ISSN0001-5482
Publication statusPublished - 1989

ID: 32503790